YESCARTA

YESCARTA is a potentially life-saving CAR T-cell therapy for non-Hodgkin lymphoma patients who haven’t responded to other treatments. I co-wrote a digital brochure that transformed this complex treatment into clear, accessible information, combining efficacy data with a detailed guide to help patients understand exactly what to expect.